Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

 4,375.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 5,060.00
  • 52 Week Low: 3,500.00
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 0
  • Market Cap: £228.36m

Fundamentals - based on IFRS

  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Income Statement 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Continuing Operations          
Revenue 6.68 5.89 4.73 5.16 5.10
Operating Profit/(Loss) 5.15 4.48 3.56 3.71 4.08
Profit Before Tax 5.24 4.52 3.56 3.72 4.10
Profit After Tax 4.02 3.73 2.99 3.10 3.43
Discontinued Operations          
Profit After Tax n/a n/a n/a n/a n/a
PROFIT FOR THE PERIOD 4.02 3.73 2.99 3.10 3.43
           
Continuing EPS          
Earnings per Share - Basic 77.09p 71.61p 57.35p 59.47p 66.65p
Earnings per Share - Diluted 75.96p 70.90p 56.79p 58.84p 65.56p
Earnings per Share - Adjusted 77.09p 71.61p 57.35p 59.47p 66.65p
Continuing and Discontinued EPS          
Earnings per Share - Basic 77.09p 71.61p 57.35p 59.47p 66.65p
Earnings per Share - Diluted 75.96p 70.90p 56.79p 58.84p 65.56p
Earnings per Share - Adjusted 77.09p 71.61p 57.35p 59.47p 66.65p
Dividend per Share 68.00p 62.00p 52.00p 43.00p 36.00p
  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Balance Sheet 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Total Non-Current Assets 1.13 1.25 1.39 1.39 9.40
Net Current Assets cn/a cn/a cn/a cn/a cn/a
Total Assets 13.15 11.71 10.63 11.21 10.70
Total Liabilities 1.71 1.25 0.90 0.90 1.00
Net Assets 11.43 10.47 9.73 10.31 9.69
           
Shareholders Funds 11.43 10.47 9.73 10.31 9.69
Minority Interests/Other Equity n/a n/a n/a n/a n/a
Total Equity 11.43 10.47 9.73 10.31 9.69

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: Forecast figures based on normalised accounts.

 

Top of Page